rituxan
Showing 1 - 20 of 20
Myeloid Diseases Trial in Middletown, New York (drug, radiation, procedure)
Recruiting
- Myeloid Diseases
- Antithymocyte globulin (Rabbit)
- +5 more
-
Middletown, New Jersey
- +1 more
Jan 19, 2023
Pompe Disease Trial in Gainesville (genetic, drug, other)
Completed
- Pompe Disease
- Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase
- +7 more
-
Gainesville, FloridaClinical and Translational Research Building (CTRB), University
Mar 24, 2022
Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)
Recruiting
- Immune Thrombocytopenic Purpura
- rituxan
-
Valhalla, New YorkNew York Medical College
Aug 4, 2021
Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Stiff-Person Syndrome
- Autologous Hematopoietic Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Non-Hodgkin's Lymphoma (NHL) Trial in Chicago (Rituxan, motexafin gadolinium, 111Indium-Zevalin and 90Yttrium-Zevalin)
Terminated
- Non-Hodgkin's Lymphoma (NHL)
- Rituxan
- +2 more
-
Chicago, Illinois
- +1 more
Jul 12, 2019
Lymphoma, Hodgkin's Disease Trial in Houston (Melphalan, Ara-C, VP-16)
Leukemia, Lymphocytic, Acute, Leukemia, Myelocytic, Acute, Leukemia, Myeloid, Chronic Trial in Houston (procedure, drug,
Completed
- Leukemia, Lymphocytic, Acute
- +3 more
- Expanded allogeneic cord blood (CB)
- +8 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Apr 10, 2019
MYOPATHY Trial in Chicago (Hematopoietic stem cell transplantation, Cyclophosphamide, Mesna)
Terminated
- MYOPATHY
- Hematopoietic stem cell transplantation
- +6 more
-
Chicago, IllinoisNorthwestern University, Feinberg School of Medicine
Nov 3, 2017
Lymphoma Trial in Omaha (Rituxan, BEAM, Autologous stem cell transplant)
Completed
- Lymphoma
- Rituxan
- +2 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center, Section of Oncology/Hemat
Jan 13, 2018
Brain and CNS Tumors, Drug/Agent Toxicity by Tissue/Organ, Lymphoma Trial in Cincinnati, Portland (Rituxan, Cyclophosphamide,
Terminated
- Brain and Central Nervous System Tumors
- +3 more
- Rituxan
- +8 more
-
Cincinnati, Ohio
- +1 more
Apr 19, 2017
Lymphoma Trial in Houston (Cytoxan, Nipent, Rituxan)
Completed
- Lymphoma
- Cytoxan
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 13, 2016
Kidney Transplantation Trial in Cincinnati (Rabbit Antithymocyte Globulin, Velcade, Rituxan)
Completed
- Kidney Transplantation
- Rabbit Antithymocyte Globulin
- +2 more
-
Cincinnati, Ohio
- +1 more
Dec 14, 2015
Endothelial Function, Rheumatoid Arthritis, Inflammation Trial in San Francisco (Rituxan)
Completed
- Endothelial Function
- +2 more
- Rituxan
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 29, 2015
Malignant Melanoma of Skin Stage III, Metastatic Melanoma Trial in Encinitas (Rituxan)
Unknown status
- Malignant Melanoma of Skin Stage III
- Metastatic Melanoma
- Rituxan
-
Encinitas, CaliforniaCalifornia Cancer Associates For Research,cCARE
May 16, 2014
Lymphoma Trial in Houston (Y Zevalin, In Zevalin, Rituxan)
Completed
- Lymphoma
- Y Zevalin
- +8 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 4, 2014
Non-Hodgkin's Lymphoma Trial in Boston (Rituxan, 1018 ISS)
Completed
- Non-Hodgkin's Lymphoma
- Rituxan
- 1018 ISS
-
Boston, Massachusetts
- +2 more
Jan 28, 2010
Peripheral Neuropathy Trial (Rituxan)
Unknown status
- Peripheral Neuropathy
- Rituxan
- (no location specified)
Jun 23, 2005